TCL Archive Scientific Misconduct: HHS To Change Role Of ORI In Response To Council Report December 3, 1999
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983